Alogliptin Delays the Healing of Traumatic Oral Ulcers in the Buccal Mucosa of Wistar Rats
Fundamental & Clinical Pharmacology · 2026-05 · 40 (3)
DOI: 10.1111/fcp.70090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, online erschienen am 23.04.2026. Verfasst von Maria Imaculada de Queiroz Rodrigues und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dental Clinic, Stomatology and Oral Pathology Sector, School of Pharmacy, Dentistry and Nursing, Federal University of Ceara, Fortaleza…. Hauptthemen laut MEDLINE: Wound Healing, Oral Ulcer, Uracil, Piperidines. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The objective of this study is to evaluate the influence of alogliptin treatment on the healing process of traumatic oral ulcers.
Methods
Four experimental groups were used: control group (GC) and three test groups treated with oral Alogliptin at 1 (GTA1), 3 (GTA3), and 9 mg/kg/day (GTA9). Ulcer diameter, body weight, glycemic index, colony‐forming unit (CFU), and discomfort were analyzed. Histological slides were prepared for healing scores, inflammatory cell counts, collagen deposition analysis, and immunohistochemistry.
Results
Alogliptin treatment increased ulcer area (GTA3‐7D: 5.2 ± 1.2; GTA9‐3D: 11.8 ± 0.8; GTA9‐7D: 5.8 ± 1.3; p < 0.001), CFU counts ( p = 0.049), and Grimace/discomfort scores ( p = 0.02), while reducing body weight gain ( p = 0.007) in GTA3 and GTA9 groups. Microscopic analysis revealed higher histopathological scores ( p = 0.039), increased mononuclear cells ( p = 0.006), reduced polymorphonuclear cells ( p < 0.05), and decreased collagen deposition (18.2 ± 2.6; p = 0.031) in GTA9. Lower TLR4 ( p = 0.001) and TGF‐β ( p < 0.001) expression, alongside increased CD31 immunostaining ( p < 0.001), were observed in GTA3 and GTA9, as well as reduced TLR2 expression ( p = 0.001) in GTA9.
Conclusion
Alogliptin delays oral ulcer healing by sustaining inflammation, reducing TGF‐β expression, and impairing collagen deposition, and may contribute via reduced TLR2/TLR4 expression, increased microbial burden, and decreased TGF‐β.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dental Clinic, Stomatology and Oral Pathology Sector, School of Pharmacy, Dentistry and Nursing, Federal University of Ceara, Fortaleza, Ceará, Brazil.
- Applied Group in Medical Microbiology, Postgraduate Program in Medical Microbiology, Faculty of Medicine, Federal University of Ceara, Fortaleza, Ceará, Brazil.
- Department of Dentistry, Unichristus, Fortaleza, Ceará, Brazil.
ORCID-Profile: Maria Imaculada de Queiroz Rodrigues, Paulo Goberlânio de Barros Silva
Zitieren
APA
de Queiroz Rodrigues, M. I., de Lima Martins, J. O., Castelo-Branco, D. S. C. M., de Barros Silva, P. G., Sousa, F. B., Mota, M. R. L., & Alves, A. P. N. N. (2026). Alogliptin Delays the Healing of Traumatic Oral Ulcers in the Buccal Mucosa of Wistar Rats. Fundamental & Clinical Pharmacology, 40(3). https://doi.org/10.1111/fcp.70090
Vancouver
de Queiroz Rodrigues MI, de Lima Martins JO, Castelo-Branco DSCM, de Barros Silva PG, Sousa FB, Mota MRL, et al. Alogliptin Delays the Healing of Traumatic Oral Ulcers in the Buccal Mucosa of Wistar Rats. Fundamental & Clinical Pharmacology. 2026;40(3). doi:10.1111/fcp.70090
BibTeX
@article{deQueirozRodrigues2026,
author = {de Queiroz Rodrigues, Maria Imaculada and de Lima Martins, Joyce Ohana and Castelo-Branco, Debora de Souza Collares Maia and de Barros Silva, Paulo Goberlânio and Sousa, Fabrício Bitu and Mota, Mário Rogério Lima and Alves, Ana Paula Negreiros Nunes},
title = {Alogliptin Delays the Healing of Traumatic Oral Ulcers in the Buccal Mucosa of Wistar Rats},
journal = {Fundamental & Clinical Pharmacology},
year = {2026},
volume = {40},
number = {3},
doi = {10.1111/fcp.70090}
}
EUVIMED